Clinical

Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
 
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
 
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
Learn More

Luminex® Blog

The Faces of Luminex: Kurt Hoffacker, Chemistry R&D

Developing immunoassay technology and platforms takes innovation and hard work on a number of fronts—hardware, software, reagents, and more. We count on Kurt Hoffacker, Director of Chemistry R&D, to ensure that reagent development goes smoothly, and ultimately leads to products that integrate well with the rest of the Luminex systems. He has been a key member of our chemistry team since 1999.

Continue Reading >

Workflow of an LDT on the ARIES® System

 
Video Thumbnail
Workflow of an LDT on the ARIES® System
  Clinical Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.  Read More Research & Applied Markets Our xMAP® Technology and its flexible, open-a

The ARIES® System from Luminex offers you the flexibility to run IVD assays, as well as design and run lab developed tests. Using SYNCT™ software, you can easily create and run your own assays with the most common PCR technologies, including TAQMAN® and MultiCode®.

Watch more videos >

Luminex on Twitter


RT @Luminex: As part of our ongoing commitment to provide our customers with flexible solutions for their current workflows, effective toda…
h J R
RT @statesman: Austin-based Luminex receives FDA approval for coronavirus test https://t.co/BtPf5rSe4l
h J R

Latest News

27th March
Luminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 Disease

13th March
Luminex Provides Update on SARS-CoV-2 Validation Testing Efforts

4th March
Luminex Provides Updates on Critical Efforts Related to Novel Coronavirus

Events

Swiss Flow Cytometry
5-7 February
Lausanne, Switzerland


Biomarkers
18-20 February
Manchester, UK